Lv1
38 积分 2021-06-24 加入
Chemical modification of PS-ASO therapeutics reduces cellular protein-binding and improves the therapeutic index
5天前
已完结
Toxicity of Antisense Oligonucleotides is Determined by the Synergistic Interplay of Chemical Modifications and Nucleotide Sequences, Not by Either Factor Alone
5天前
已完结
Blood injections in multiple sclerosis
5天前
已关闭
LQT3: Who is at risk for sudden cardiac death?
3个月前
已关闭
SCN5A missense variants and their contribution to deaths in Sudden Unexplained Nocturnal Death Syndrome (SUNDS)
3个月前
已完结
Variant-specific therapy for long QT syndrome type 3
3个月前
已关闭
SCN5A gene variants and arrhythmic risk in Brugada syndrome: An updated systematic review and meta-analysis
3个月前
已完结
A consensus guide to preclinical indirect calorimetry experiments
6个月前
已完结
Discovery of long-acting APOC3 siRNA for treating patients with hypertriglyceridemia
6个月前
已完结
OS-030 Efficacy and safety of xalnesiran with and without an immunomodulator in virologically suppressed participants with chronic hepatitis B: end of study results from the phase 2, randomized, controlled, adaptive, open-label platform study (PIRANGA)
7个月前
已完结
皖公网安备34019202002308
